Sex and age differences of major cardiovascular events in patients after percutaneous coronary intervention

医学 狼牙棒 传统PCI 心力衰竭 内科学 经皮冠状动脉介入治疗 冠状动脉疾病 冲程(发动机) 心脏病学 单变量分析 心肌梗塞 多元分析 机械工程 工程类
作者
Ya‐Ling Yang,Su‐Chan Chen,Yu‐Feng Hu,Shao‐Sung Huang,Wan Leong Chan,Shing‐Jong Lin,Chia‐Yu Chou,Jaw‐Wen Chen,Ju‐Pin Pan,Min‐Ji Charng,Ying‐Hwa Chen,Tao‐Cheng Wu,Tse‐Min Lu,Pai‐Feng Hsu,Po‐Hsun Huang,Hao‐Min Cheng,Chin‐Chou Huang,Shih-Hsien Sung,Yenn‐Jiang Lin,Hsin‐Bang Leu
出处
期刊:Journal of The Chinese Medical Association [Ovid Technologies (Wolters Kluwer)]
卷期号:86 (12): 1046-1052 被引量:1
标识
DOI:10.1097/jcma.0000000000001011
摘要

Women usually have higher risk after receiving percutaneous coronary interventions (PCIs) than men with coronary artery disease (CAD). The aim of this study was to investigate the association of sex differences with future outcomes in CAD patients undergoing PCI, to assess the role of age, and to extend observed endpoints to stroke and congestive heart failure.Six thousand six hundred forty-seven patients with CAD who received successful PCIs. The associations between clinic outcomes and sex were analyzed. The primary outcome was major cardiovascular events (MACE), including cardiac death, nonfatal myocardial infraction, and nonfatal stroke. The secondary outcome was MACE and hospitalization for heart failure (total CV events).During a mean of 52.7 months of follow-up, 4833 men and 1614 women received PCI. Univariate and multivariate analyses showed that women were independently associated with an increased risk of cardiac death (HR, 1.78; 95% CI, 1.32-2.41), hospitalization for heart failure (HR, 1.53; 95% CI, 1.23-1.89), MACE (HR, 1.34; 95% CI, 1.10-1.63), and total CV events (HR, 1.39; 95% CI, 1.20-1.62). In the subgroup analysis, women aged under 60 years had higher cardiovascular risks than men of the same age category.Women with CAD after successful PCI had poorer cardiovascular outcomes than men. Additionally, younger women (aged <60 years) were especially associated with a higher risk of developing future adverse cardiovascular outcomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Wyoou完成签到,获得积分10
1秒前
1秒前
1秒前
故意的傲玉应助lll采纳,获得10
1秒前
2秒前
请叫我风吹麦浪应助lm采纳,获得10
2秒前
2秒前
2秒前
3秒前
科研通AI5应助水獭采纳,获得10
4秒前
4秒前
4秒前
研友_nv2r4n发布了新的文献求助10
5秒前
喵叽发布了新的文献求助10
5秒前
槐夏完成签到,获得积分10
5秒前
6秒前
科研通AI5应助su采纳,获得10
6秒前
6秒前
科目三应助MJQ采纳,获得30
6秒前
6秒前
慕子发布了新的文献求助20
7秒前
lumangxiaozi完成签到,获得积分10
7秒前
积极的凌波完成签到,获得积分10
7秒前
xiaxiao应助小小酥采纳,获得100
7秒前
523完成签到,获得积分10
7秒前
7秒前
8秒前
9秒前
9秒前
Hupoo发布了新的文献求助10
9秒前
传奇3应助冬瓜有内涵呐采纳,获得10
9秒前
9秒前
酷波er应助科研通管家采纳,获得10
10秒前
SciGPT应助科研通管家采纳,获得10
10秒前
顾矜应助科研通管家采纳,获得10
10秒前
Aurora发布了新的文献求助10
10秒前
10秒前
Ava应助科研通管家采纳,获得10
10秒前
Chen发布了新的文献求助10
10秒前
prosperp应助科研通管家采纳,获得10
10秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527723
求助须知:如何正确求助?哪些是违规求助? 3107826
关于积分的说明 9286663
捐赠科研通 2805577
什么是DOI,文献DOI怎么找? 1539998
邀请新用户注册赠送积分活动 716878
科研通“疑难数据库(出版商)”最低求助积分说明 709762